Last Updated: September 24, 2026

Jubilant Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for JUBILANT

JUBILANT has eighty-nine approved drugs.

Summary for Jubilant

US Patents:	0
Tradenames:	80
Ingredients:	76
NDAs:	89
Patent Litigation for Jubilant:	See patent lawsuits for Jubilant

Drugs and US Patents for Jubilant

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Jubilant Cadista	PREDNISONE	prednisone	TABLET;ORAL	040362-004	Apr 17, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant Generics	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	205482-002	Apr 24, 2017	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant Cadista	ALENDRONATE SODIUM	alendronate sodium	TABLET;ORAL	090557-003	Feb 18, 2010		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant Generics	CELECOXIB	celecoxib	CAPSULE;ORAL	207061-002	Apr 4, 2017		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant	HICON	sodium iodide i-131	SOLUTION;ORAL	021305-003	Jan 24, 2003		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant Generics	VALACYCLOVIR HYDROCHLORIDE	valacyclovir hydrochloride	TABLET;ORAL	201506-002	Apr 3, 2012	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant Generics	IRBESARTAN	irbesartan	TABLET;ORAL	203534-003	Feb 23, 2015	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.